Aversion Quote by Peter Lynch
“My high-tech aversion caused me to make fun of the typical biotech enterprise: $100 million in cash from selling shares, one hundred Ph.D.'s, 99 microscopes, and zero revenues.”
About This Quote
Source Interview: CNBC, 2015
The speaker mocks biotech firms that raise huge capital without generating sales, highlighting a mismatch between funding and revenue.
In simple terms: Biotech firms often have lots of money and staff but no profit.
Key Takeaway
Beware of companies with high cash but no earnings.
Themes
finance
biotech
valuation
risk
investment
Mood
skeptical
analytical
Type
cautionary
financial.
When to use this quote
- venture capital assessment
- stock analysis
- portfolio diversification
- due diligence
- risk management
Key Concepts
capital efficiency
business model
market expectations
Questions to Reflect On
- How do you evaluate a biotech with no revenue?
- What metrics indicate sustainable growth?
A Different Perspective
High cash reserves can mask underlying business flaws.
